Covid-19 vaccine “v-01” of Joincare Pharmaceutical Group Industry Co.Ltd(600380) has been applied for listing

On February 18, Joincare Pharmaceutical Group Industry Co.Ltd(600380) and Livzon Pharmaceutical Group Inc(000513) relevant management further explained the details of covid-19 vaccine v-01. Zhu Baoguo, chairman of Joincare Pharmaceutical Group Industry Co.Ltd(600380) and Livzon Pharmaceutical Group Inc(000513) , said, “the company has officially applied to the State Food and Drug Administration for registration and approval, and all documents have been submitted. The international community is also actively preparing for the application for listing in many places, and the company has been carrying out the certification of who at the same time.”